September Marks Inherited Retinal Disease Awareness Month

Canada is marking September as the first annual Inherited Retinal Disease Awareness Month, resulting from advocacy efforts by Fighting Blindness Canada (FBC) to Health Canada to recognize individuals living with genetic conditions that lead to vision loss. Inherited retinal diseases (IRDs) are caused by a specific genetic mutation or mutations that impact how retinal cells work and survive which impact vision.

“Researchers have found more than 300 genes that cause IRDs, which cause damage to the retina in the back of the eye and ultimately lead to vision loss, either at birth or later in life,” explains Doug Earle, President and CEO of Fighting Blindness Canada (FBC). “However, research is constantly changing the outcomes for people living with these conditions. There are new treatments that can slow down, stop or even reverse the progression of disease, giving people immense hope of a future without blindness.”

FBC commissioned Deliotte Access Economics to deliver “IRD Counts” in 2020 that identified the annual socio-economic impact of IRDs in Canada as $1.6 billion. Over 80% of the impact is borne by families living with IRDs.

Although there are differences between IRDs, they all result in vision loss due to retinal damage in the back of the eye. Among the more than 20 types of IRDs include retinitis pigmentosa, Stargardt disease, Usher syndrome, and Leber congenital amaurosis. Genetic testing may help pinpoint which mutation causes an IRD and can provide important information as more clinical trials and treatments are developed.

As part of IRD Awareness Month, FBC is inviting Canadians to participate in the following:

Click HERE for the full press release.

Featured Posts

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read More

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read More

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read More

Winners of the 30th SILMO d’Or

And here are the winners!

Read More

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more